Skip to main content
. 2020 Oct 7;9(1):2212–2221. doi: 10.1080/22221751.2020.1826892

Figure 4.

Figure 4.

Cumulative incidence of seroconversion of IgG/M against SARS- CoV-2 among COVID-19 patients (A) after RT-PCR testing; and (B) after onset of first symptoms.